Objective: To evaluate the use of cardiovascular medications in patients with and without heart failure after myocardial infarction (MI).
Design And Setting: Multicentre study of drug therapy for patients with MI in 16 major metropolitan teaching hospitals in Australia over a 1-month period at each hospital in the period November 2004 - March 2005.
Participants: 479 patients admitted consecutively to the individual hospitals.